0001524679-15-000002.txt : 20150624 0001524679-15-000002.hdr.sgml : 20150624 20150624182019 ACCESSION NUMBER: 0001524679-15-000002 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150517 FILED AS OF DATE: 20150624 DATE AS OF CHANGE: 20150624 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Immune Response BioPharma, Inc. CENTRAL INDEX KEY: 0001524679 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 15950192 BUSINESS ADDRESS: STREET 1: 244 5TH AVENUE SUITE 1727 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 5407600535 MAIL ADDRESS: STREET 1: 244 5TH AVENUE SUITE 1727 CITY: NEW YORK STATE: NY ZIP: 10001 3 1 primary_doc.xml PRIMARY DOCUMENT X0206 3 2015-05-17 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001524679 Immune Response BioPharma, Inc. 244 5TH AVENUE SUITE 1727 NEW YORK NY 10001 0 0 0 1 Shareholder PDL Stock 1 D Initial ownership of PDL one share by Immune Response BioPharma, Inc. David Buswell 2015-06-24